Indolent lymphoma is a type of lymphoma or blood cancer that can be silent because it grows and spreads slowly, sometimes without causing any symptoms. “I faced some of the most challenging ...

Lymphomas are classified as “aggressive” if they’re expected to progress quickly and “indolent” if they’re slow-growing. The overall 5-year relative survival rate of DLBCL is 65% ...

There are two main categories of NHL: indolent and aggressive. According to the NCI, aggressive lymphomas do not typically return after successful treatment. However, indolent lymphomas often ...

The treatment aims to treat patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma. Indolent lymphomas are a rare type of lymphoma that tend to grow more slowly and have fewer ...

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

These investigators used SEER data to compare the outcomes of transformed indolent non-Hodgkin lymphomas with de novo DLBCL at a population level, a situation for which little data exist.

Bristol-Myers Squibb (NYSE:BMY) recently gained European Commission approval for Breyanzi, broadening treatment options for ...

and nodal marginal zone lymphoma (NMZL). In addition, pediatric-type FL and NMZL, both indolent conditions, need to be differentiated from atypical lymphoid hyperplasia of the lymph nodes and tonsils.

Dr. Gopal also conducts clinical research on low-toxicity drugs for patients with indolent lymphomas that activate the cancer cells’ self-destruct mechanism. Finally, Dr. Gopal studies new strategies ...